A clinical trial of creatine in ALS.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/15534251
Conclusion of this study
Any beneficial effect of creatine at 5 g per day in ALS must be small. Other agents should be considered in future studies of therapeutic agents to address mitochondrial dysfunction in ALS. In addition, motor unit number estimation may be a useful outcome measure for future clinical trials in ALS.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
||
|
||
|
Body systems related to this study
Digestive System |
Muscular System |